These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8560578)

  • 1. The role of endogenous glucocorticoids on host T cell populations in the peripheral lymphoid organs of mice with graft-versus-host disease.
    You-Ten KE; Lapp WS
    Transplantation; 1996 Jan; 61(1):76-83. PubMed ID: 8560578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of a glucocorticoid-sensitive F1-anti-parental mechanism that affects engraftment during graft-versus-host disease.
    You-Ten KE; Seemayer TA; Wisse B; Bertley FM; Lapp WS
    J Immunol; 1995 Jul; 155(1):172-80. PubMed ID: 7602093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic analysis of donor cells infiltrating the small intestinal epithelium and spleen during graft-versus-host disease.
    Schattenfroh NC; Hoffman RA; McCarthy SA; Simmons RL
    Transplantation; 1995 Jan; 59(2):268-73. PubMed ID: 7839451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of CD4+ and CD8+ cells in normal F1 hybrid host in the resistance to lethal graft-versus-host disease induction by transfer of parent spleen cells.
    Kitajima T; Iwashiro M; Kuribayashi K; Imamura S
    Immunol Lett; 1994 Jun; 40(3):207-10. PubMed ID: 7959888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment.
    Drobyski WR; Majewski D; Ozker K; Hanson G
    J Immunol; 1998 Sep; 161(5):2610-9. PubMed ID: 9725263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of purified CD8+ T cells in graft-versus-leukemia activity and engraftment after allogeneic bone marrow transplantation.
    Palathumpat V; Dejbakhsh-Jones S; Strober S
    Transplantation; 1995 Aug; 60(4):355-61. PubMed ID: 7652765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell subsets involved in lethal graft-versus-host disease directed to immunodominant minor histocompatibility antigens.
    Berger M; Wettstein PJ; Korngold R
    Transplantation; 1994 Apr; 57(7):1095-102. PubMed ID: 7909395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell subsets in the thymus of graft-versus-host immunosuppressed mice. Sensitivity of the L3T4+Lyt-2- subset to cortisone.
    Kornbluth M; You-Ten E; Desbarats J; Gamache S; Xenocostas A; Lapp WS
    Transplantation; 1991 Jan; 51(1):262-7. PubMed ID: 1987697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets.
    Johnson BD; Becker EE; Truitt RL
    Biol Blood Marrow Transplant; 1999; 5(3):123-32. PubMed ID: 10392958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biased liver T cell receptor V beta repertoire in a murine graft-versus-host disease model.
    Howell CD; Li J; Roper E; Kotzin BL
    J Immunol; 1995 Sep; 155(5):2350-8. PubMed ID: 7650370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The balance between donor T cell anergy and suppression versus lethal graft-versus-host disease is determined by host conditioning.
    Gonzalez M; Quezada SA; Blazar BR; Panoskaltsis-Mortari A; Rudensky AY; Noelle RJ
    J Immunol; 2002 Nov; 169(10):5581-9. PubMed ID: 12421935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific donor Vbeta-associated CD4 T-cell responses correlate with severe acute graft-versus-host disease directed to multiple minor histocompatibility antigens.
    Jones SC; Friedman TM; Murphy GF; Korngold R
    Biol Blood Marrow Transplant; 2004 Feb; 10(2):91-105. PubMed ID: 14750075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease.
    Krenger W; Snyder KM; Byon JC; Falzarano G; Ferrara JL
    J Immunol; 1995 Jul; 155(2):585-93. PubMed ID: 7608537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-2 reduces graft-versus-host disease and preserves a graft-versus-leukemia effect by selectively inhibiting CD4+ T cell activity.
    Sykes M; Abraham VS; Harty MW; Pearson DA
    J Immunol; 1993 Jan; 150(1):197-205. PubMed ID: 8093257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granzyme B-Mediated Activation-Induced Death of CD4+ T Cells Inhibits Murine Acute Graft-versus-Host Disease.
    Du W; Leigh ND; Bian G; O'Neill RE; Mei L; Qiu J; Chen GL; Hahn T; Liu H; McCarthy PL; Cao X
    J Immunol; 2015 Nov; 195(9):4514-23. PubMed ID: 26392464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inter-strain tissue-infiltrating T cell responses to minor histocompatibility antigens involved in graft-versus-host disease as determined by Vbeta spectratype analysis.
    Zilberberg J; McElhaugh D; Gichuru LN; Korngold R; Friedman TM
    J Immunol; 2008 Apr; 180(8):5352-9. PubMed ID: 18390717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of CD8+ and CD4+ cells on lethal graft-versus-host disease in nude mice.
    Uenaka A; Kuribayashi K; Nakayama E
    Transpl Immunol; 1993; 1(2):132-6. PubMed ID: 7915951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory role of host CD8+ T lymphocytes in experimental graft-versus-host disease across a single major histocompatibility complex class II incompatibility.
    de Lavareille A; Prigogine C; Paulart F; Nagy N; Habran C; Haddou NO; Le Moine A; Salmon I; Goldman M; Flamand V
    Transplantation; 2005 Nov; 80(9):1293-9. PubMed ID: 16314798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses to major histocompatibility complex homozygous lymphoid cells in murine F1 hybrid recipients: implications for transfusion-associated graft-versus-host disease.
    Fast LD; Valeri CR; Crowley JP
    Blood; 1995 Oct; 86(8):3090-6. PubMed ID: 7579403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of responding CD4+ and CD8+ T-cell repertoires during the development of graft-versus-host disease directed to minor histocompatibility antigens.
    Friedman TM; Jones SC; Statton D; Murphy GF; Korngold R
    Biol Blood Marrow Transplant; 2004 Apr; 10(4):224-35. PubMed ID: 15077221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.